[an error occurred while processing this directive] ����Ƥ���Բ�ѧ��־ 2012, 38(3) 206-208 DOI:     ISSN: 2096-5540 CN: 32-1880/R

����Ŀ¼ | ����Ŀ¼ | ������� | �߼�����                                                            [��ӡ��ҳ]   [�ر�]
����
��չ����
������Ϣ
Supporting info
PDFȫ��
[HTMLȫ��]
�����
�����뷴��
�ѱ����Ƽ�������
�����ҵ����
�������ù�����
����
Email Alert
���·���
���������Ϣ
���Ĺؼ����������
��������ҩ��
���������������
�Ž���
���ػ�
PubMed
Article by Zhang,J.X
Article by Ji,B.H

����ù���࿹��������÷������ҩ��״������

�Ž���1,���ػ�2

1. ����ҽѧԺ
2. �����ߺ�,����ҽѧԺ����߮�ɽҽԺƤ���Բ���

ժҪ��

Ŀǰ��÷��������������ѡ��ù�أ�������ù�ش���ҩ����������⣬�����໼�ߣ��ٴ��ϳ�ѡ�ô������ࡢ�Ļ�����͵�����ͷ�߾�����Ϊ������Ʒ������ж������غ�ͷ������������н�С����ҩ�Կ���Ϊ��ѡ�����ҩ���ʹ��ͷ������ʱӦ��������Ϊ���ܴ��ں���ù�صĽ�����������������࿹���أ��ر��ǰ���ù�ص��ٴ���ҩ�Խϸߣ�ֻ����Ϊ��������´�ѡ���ҩ�÷��������Ը������ҩ�����ҩ����ҩ��Ŀ������Ƽ�ijЩ÷�����������͵Ļ���ͻ���йء�

�ؼ����� ��������ҩ��  

Resistance of Treponema pallidum to non-penicillin antibiotics: present status and mechanisms

Abstract:

Penicillin is the preferred drug for treating syphilis at present, although penicillin allergy has been a serious problem. For penicillin-allergic patients with syphilis, macrolides, tetracyclines and third-generation cephalosporins can be applied. Of these alternatives, doxycycline and ceftriaxone can serve as the primary choice for their strong antimicrobial activity. However, ceftriaxone should be used with caution for the possible cross allergy with penicillin. Macrolides, especially azithromycin, can only serve as a second-line treatment in specific conditions for the high resistance rate in clinical practice. The resistance of Treponema pallidum to these alternative drugs is associated with antimicrobial mechanisms of drugs and gene mutations in some Treponema pallidum strains.

Keywords: Antibiotic -resistance  
�ո����� 2011-11-01 �޻����� 2011-11-25 ����淢������ 2012-05-03 
DOI:
������Ŀ:

ͨѶ����: ���ػ�
���߼��:

�ο����ף�

[1] Workowski KA, Berman S; Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines, 2010. MMWR Recomm Rep. 2010 Dec 17;59(RR-12):1-110.
[2] Roberts MC. Update on macrolide-lincosamide-streptogramin, ketolide, and oxazolidinone resistance genes. FEMS Microbiol Lett. 2008 May;282(2):147-59.
[3] SOUTH MA, SHORT DH, KNOX JM.FAILURE OF ERYTHROMYCIN ESTOLATE THERAPY IN IN UTERO SYPHILIS. JAMA. 1964 Oct 5;190:70-1.
[4] Katz KA, Klausner JD.Azithromycin resistance in Treponema pallidum.Curr Opin Infect Dis. 2008 Feb;21(1):83-91.
[5] Centers for Disease Control and Prevention (CDC).Azithromycin treatment failures in syphilis infections--San Francisco, California, 2002-2003.MMWR Morb Mortal Wkly Rep. 2004 Mar 12;53(9):197-8.
[6] Mitchell SJ, Engelman J, Kent CK, et al.Azithromycin-resistant syphilis infection: San Francisco, California, 2000-2004.Clin Infect Dis. 2006 Feb 1;42(3):337-45.
[7] Ghanem KG, Erbelding EJ, Cheng WW, et al.Doxycycline compared with benzathine penicillin for the treatment of early syphilis. Clin Infect Dis. 2006 Mar 15;42(6):e45-9.
[8] Kang-Birken SL, Castel U, Prichard JG.. Oral doxycycline for treatment of neurosyphilis in two patients infected with human immunodeficiency virus.Pharmacotherapy. 2010 Apr;30(4):119e-22e.
[9] Onoda Y.Therapeutic effect of oral doxycycline on syphilis. Br J Vener Dis. 1979 Apr;55(2):110-5.
[10] Johnson RC, Bey RF, Wolgamot SJ.Comparison of the activities of ceftriaxone and penicillinG against experimentally induced syphilis in rabbits. Antimicrob Agents Chemother. 1982 Jun;21(6):984-9.
[11] Zhou P, Gu Z, Xu J, et al. A study evaluating ceftriaxone as a treatment agent for primary and secondary syphilis in pregnancy. Sex Transm Dis. 2005 Aug;32(8):495-8.
[12] Spornraft-Ragaller P, Abraham S, Lueck C, et al.Response of HIV-infected patients with syphilis to therapy with penicillin or intravenous ceftriaxone. Eur J Med Res. 2011 Feb 24;16(2):47-51.
[13] Lukehart SA, Godornes C, Molini BJ, et al.Macrolide resistance in Treponema pallidum in the United States and Ireland. N Engl J Med. 2004 Jul 8;351(2):154-8
[14] Vester B, Douthwaite S.Macrolide resistance conferred by base substitutions in 23S rRNA.
Antimicrob Agents Chemother. 2001 Jan;45(1):1-12.
[15] Matejková P, Flasarová M, Zákoucká H, et al.Macrolide treatment failure in a case of secondary syphilis: a novel A2059G mutation in the 23S rRNA gene of Treponema pallidum subsp. pallidum. J Med Microbiol. 2009 Jun;58(Pt 6):832-6.
[16] Stamm LV.Global challenge of antibiotic-resistant Treponema pallidum.Antimicrob Agents Chemother. 2010 Feb;54(2):583-9.
[17 ] Wu JY, Kim JJ, Reddy R, et al.Tetracycline-resistant clinical Helicobacter pylori isolates with and without mutations in 16S rRNA-encoding genes. Antimicrob Agents Chemother. 2005 Feb;49(2):578-83.
[18] Pringle M, Fellstr?m C, Johansson KE.Decreased susceptibility to doxycycline associated with a 16S rRNA gene mutation in Brachyspira hyodysenteriae. Vet Microbiol. 2007 Jul 20;123(1-3):245-8.
[19] Matejková P, Strouhal M, Smajs D, et al.Complete genome sequence of Treponema pallidum ssp. pallidum strain SS14 determined with oligonucleotide arrays. BMC Microbiol. 2008 May 15;8:76.
[20] Zapun A, Contreras-Martel C, Vernet T. Penicillin-binding proteins and beta-lactam resistance. FEMS Microbiol Rev. 2008 Mar;32(2):361-85.
[21] Cha JY, Ishiwata A, Mobashery S.A novel beta-lactamase activity from a penicillin-binding protein of Treponema pallidum and why syphilis is still treatable with penicillin. J Biol Chem. 2004 Apr 9;279(15):14917-21.

�������������

�������� (��ע��:��վʵ�������Ը�, �벻Ҫ������ѧ���޹ص�����!�������ݲ�����վ�۵�.)

Copyright 2008 by ����Ƥ���Բ�ѧ��־